FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Safety Labeling Changes for Fluorouracil Injection

FDA approves safety labeling changes for fluorouracil injection products when used in patients with dihydropyrimidine dehydrogenase deficiency.

latest-news-card-1
Medical Devices

Vyaire Recalls AirLife Resuscitators

Vyaire Medical recalls certain AirLife Manual Resuscitators due to a manufacturing defect.

latest-news-card-1
Medical Devices

Hearing Challenges FDA Rule on LDTs

A House Energy and Commerce Health Subcommittee hearing discusses the need to legislatively reform FDAs oversight of laboratory-developed tests instea...

latest-news-card-1
Human Drugs

Phase 3 Keytruda Miss in Lung Cancer

Merck says its Phase 3 KEYLYNK-006 trial evaluating Keytruda (pembrolizumab) in combination with maintenance Lynparza (olaparib) did not meet its prim...

latest-news-card-1
Human Drugs

Abiomed Recalls Impella Blood Pumps

Abiomed recalls its Impella Left Sided Blood Pumps because the pump catheter may slice the hearts left ventricle wall during procedures.

latest-news-card-1
Medical Devices

Elixir Gets Breakthrough for DynamX BTK

FDA grants Elixir Medical a breakthrough device designation for its DynamX BTK System, an adaptive implant for use in treating narrowed or blocked ves...

latest-news-card-1
Medical Devices

Panel to Discuss Non-invasive Ocular Pump

FDA asks the Ophthalmic Devices Panel to discuss safety and other issues related to the Balance Ophthalmics FSYX ocular pump to lower intraocular pres...

latest-news-card-1
Human Drugs

Key Patient Long Covid Meeting Themes

FDA reports the key themes that emerged from a 3/2023 virtual meeting with patients and caregivers on long Covid.

latest-news-card-1
Human Drugs

Check Key Info in Informed Consent

Two SheppardMullin attorneys analyze a recent FDA draft guidance on informed consent and suggest steps that clinical trial sponsors, investigators, an...

latest-news-card-1
Human Drugs

Non-Interventional Studies Guidance

FDA publishes a draft guidance on using non-interventional studies for drug and biological products to develop real-world evidence.